🇺🇸 FDA
Pipeline program

EPLERENONE

SCARF-1

Phase 2 small_molecule active

Quick answer

EPLERENONE for Heart failure with reduced ejection fraction in combination with severe chronic kidney disease is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Heart failure with reduced ejection fraction in combination with severe chronic kidney disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials